Discuss how pharmacogenomics affects drug response in people

This assignment asks you to discuss how pharmacogenomics affects drug response and build a concept map illustrating it across various illnesses, supported by the provided article. Explain the genetics-to-response link clearly, then map it visually.

Key takeaways

• Pharmacogenomics studies how a person’s genes affect their response to drugs.
• Genetic variation in drug-metabolizing enzymes (e.g., CYP450) changes efficacy and toxicity.
• It drives personalized medicine — right drug, right dose, right patient.
• Give disease examples (cancer, cardiovascular, psychiatric) with gene–drug pairs.
• Build a concept map linking genes → metabolism → response, and cite the article.

Explain the mechanism

Describe how genetic differences affect pharmacokinetics (how the body processes a drug) and pharmacodynamics (how the drug acts). Variations in drug-metabolizing enzymes — especially the CYP450 family — make people poor, normal, or ultra-rapid metabolizers, which changes drug levels, effectiveness, and risk of side effects. Transporters and drug-target genes matter too.

Give clinical examples

• Oncology: HER2 status guiding trastuzumab; TPMT variants and thiopurine toxicity.
• Cardiology: CYP2C19 variants affecting clopidogrel response; VKORC1/CYP2C9 and warfarin dosing.
• Psychiatry: CYP2D6/CYP2C19 variation affecting antidepressant metabolism.

These show why genotype-guided prescribing improves outcomes.

Build the concept map

Structure it from a central node (‘Pharmacogenomics → drug response’) branching to: genes/variants → enzyme activity (metabolizer status) → drug level → efficacy/toxicity, with disease-specific examples as sub-branches. Keep links labeled so the cause-and-effect reads clearly.

Format

Support your discussion with the provided article and cite it; keep the concept map clean and readable.